Summary We examined the association of serum 25-hydroxyvitamin D [25(OH)D] with indices of bone quality in older men. Positive associations for 25(OH)D and bone mineral density, content, cortical thickness, and axial and polar strength strain indices were observed among Caucasians; however, among men of African descent findings were either null or negative.
Introduction There are limited data on serum 25(OH)D and bone measures in men of African ancestry. To better understand racial differences in vitamin D status and bone health, a cross-sectional study among 446 Caucasian men in the US and 496 men of African ancestry in Tobago (age ≥ 65 years) was conducted. [1] and decreases with advancing age [2] . The possible mechanisms for the age-related loss in serum 25 (OH)D include lower vitamin D intake, decreased vitamin D absorption, limited sun exposure, and decreased cutaneous synthesis of vitamin D [3] . Vitamin D deficiency has a profound impact on bone growth and bone mineralization in young adults and on bone loss in older adults [4] .
Methods Serum 25(OH)D (liquid chromatography and tandem mass spectrometry) was measured, and peripheral

Introduction
Serum 25-hydroxyvitamin D [25(OH)D] is an indicator of vitamin D nutritional status
Low bone mineral density (BMD) and osteoporosis are growing clinical and public health problems among older men [5] . Positive [2, 3, [6] [7] [8] [9] [10] and null [11] [12] [13] associations between serum 25(OH)D concentrations and areal bone mineral density (aBMD) have been reported in men; however, limitations of past studies include small sample sizes, inadequate adjustment for potential confounders, reliance on dual X-ray absorptiometry (DXA) assessments of aBMD, and the use of unreliable radioimmunoassay methods to measure serum 25(OH)D levels. For example, Binkley et al. found markedly different serum 25(OH)D values after comparing radioimmunoassay (RIA) and competitive binding protein assays to high performance liquid chromatography (HPLC) [14] . The use of RIA or competitive binding protein assays have been shown to overestimate 25(OH)D levels and have poorer reliability compared to HPLC and liquid chromatography tandem mass spectrometry (LC-MS/MS) methods [15, 16] . Moreover, most studies have focused on Caucasian men; there are limited data on serum 25(OH)D concentrations and BMD and skeletal geometry in men of African ancestry residing in the Caribbean.
In the current study, we determined the associations between serum 25(OH)D levels measured using LC-MS/ MS and bone mineral content (BMC), trabecular and cortical volumetric BMD, and bone structural geometry at the radius and tibia among older men of Caucasian and African descent. We hypothesize that associations of serum 25(OH)D status and measures of bone quality will differ by race after adjusting for potential confounders.
Methods
Study population
The Osteoporotic Fractures in Men Study (MrOS) initially recruited 5,995 men ages 65 and older from March 2000 through April 2002 as previously described [17, 18] . Men with a history of bilateral hip replacement and men who were unable to walk without the assistance of another person were excluded from MrOS. Five thousand two hundred twentynine men (95.5% of survivors) completed some portion of the second visit between March 21, 2005 and May 3, 2006. For the current 25(OH)D substudy, the Pittsburgh center of MrOS was included for this analysis. A sample of 446 Caucasian subjects that had peripheral quantitative computed tomography (pQCT) measurements at second visit were selected to have their serum assayed for 25(OH)D.
Between 1997 and 2003, 3,170 men aged 40 years or older were recruited for a prostate cancer screening study on the Island of Tobago [19] . Age-eligible men had to be ambulatory, non-institutionalized, and not terminally ill. Between 2004 and 2007, 2,482 men (70% of survivors) completed a second clinic visit. There were 618 AfroCaribbean men aged ≥ 65 years (with all four grandparents of African ancestry) at this second visit. A random sample of 496 of these men were chosen for the substudy 25(OH)D.
Our cross-sectional study compared 446 Caucasian men to 496 men of African ancestry. The Institutional Review Board for the University of Pittsburgh and the Tobago Division of Health and Social Services approved the study protocol, and written informed consent was obtained from all participants prior to data collection.
Measurement of 25(OH)D
Measures for 25(OH)D 2 (derived from ergocalciferol) and 25(OH)D 3 (derived from cholecalciferol) in both cohorts were performed simultaneously at the Mayo Clinic by conventional LC-MS/MS as previously described in serum collected after an overnight fast and frozen until assay [20] . Samples from both cohorts were included in each assay run. The minimum detectable limit for 25(OH)D 2 was 4 ng/mL and for 25(OH)D 3 was 2 ng/mL. The number of men with detectable 25(OH)D 2 was 193 (20.5%), similar to a prior report [3] . The total 25(OH)D was quantified as the sum of 25(OH)D 2 and 25(OH)D 3 . Reliability was assessed by measuring 46 duplicate 25 (OH)D 3 samples and the coefficient of variation (CV) was 5.8% for total 25(OH)D.
Peripheral QCT measurements QCT examinations at both sites were performed on the Stratec XCT 2000 scanner with a voxel size of 0.5 mm and scan speed of 25 mm/s. Trabecular bone properties were measured by taking an ultra distal slice at 4% of the length of the radius and tibia. Variables measured at this site included total cross-sectional area (square millimeter), total BMC (milligrams per millimeter), trabecular volumetric bone mineral density (vBMD) (milligrams per cube centimeter), and the polar (SSIp) and axial (SSIx) strength strain index (cube millimeter). Cortical bone properties were measured at a region 33% of the length of the radius and tibia. Measurements at this site included cross-sectional area (square millimeter), total BMC (milligrams per millimeter), cortical vBMD (milligrams per cube centimeter), cortical thickness (millimeter), and SSIp and SSIx (cube millimeter). The strength strain indices denote the density-weighted polar or axial section moduli and reflect the torsional and bending rigidity of the long bone shaft. High-quality assessment of bone mineral properties by pQCT was assured by minimizing participant movement. A quality assurance (QA) phantom scan was scanned daily and used to monitor the stability of each pQCT scanner. QA insured that density (attenuation) of the phantom did not change by more than ±0.5% which would be logged as a failure. A cross-calibration check was also performed between the centers. The European forearm phantom was scanned three times at each site at 200, 100, and 50 mg/cm 3 , respectively. CVs were determined by repeating pQCT scans on 15 subjects with repositioning (CV ≤ 2.1%) [21] .
Potential confounders
Questionnaires and clinical evaluations were administered by trained clinical staff [17] . Demographic, lifestyle, and medical characteristics were obtained entirely through selfreport with the exception of diabetes. Men were classified as having diabetes if they self-reported a diagnosis of diabetes, took insulin, or hypoglycemic medications (baseline or second visit), or had glucose levels ≥ 126 mg/dl after a minimum of an 8-h fast.
All variables for MrOS with the exception of education (attended college vs. never attended college), history of fracture, and alcohol intake (drinks per week), dietary calcium (milligrams per day), supplemental calcium (yes or no), and health status (excellent/good vs. fair/poor/very poor) were obtained at second visit. Season of blood draw was coded as winter, January-March; spring, April-June; summer, July-September; fall, October-December. A calibrated balance beam scale was used to measure body weight in kilograms. Participants wore indoor clothing and removed their shoes when their weight was being measured. Height was measured in centimeters using a Harpenden Stadiometer (Dyfed, UK) or wall mounted height board. BMI was calculated using weight (in kilograms) over height (in square meters). A self-report of current smoking (yes or no), caffeine intake (milligrams per day), and average time walking per day in the past 7 days (≤1 h, >1 h) were also determined. Dietary information on calcium and caffeine intake in MrOS was obtained using the modified Block Food Frequency [22] . Caffeine intake was assessed in the Tobago Bone Health Study by assuming that one cup of caffeinated coffee, tea, or soda contained 95, 55, and 45 mg of caffeine, respectively. Dietary calcium intake in this population was determined by the frequency of selected food items, including fish, bone chewing, green leafy vegetables, beans, milk, cheese, and cheese dishes that contain high dietary calcium and are frequently consumed in the local diet [21] . Subjects were asked to report if a doctor or health care provider informed them they had certain medical conditions, including history of fracture, hypertension, myocardial infarction, osteoporosis, osteoarthritis, and rheumatoid arthritis (RA).
Statistical analysis
We defined 25(OH)D "deficiency" as <20 ng/ml, "insufficiency" as 20 to < 30 ng/ml, and "sufficiency" as ≥30 ng/ml based on previous reports [1] . Chi-square tests for categorical variables and analysis of variance for continuous variables were performed to test if baseline characteristics differed by 25(OH)D status. The Kruskal-Wallis test was used if a continuous variable was not normally distributed. Racespecific linear regression analysis was used to calculate the least square means and examine associations between 25 (OH)D and pQCT parameters. A Bonferroni correction was used to adjust for pairwise comparisons between 25(OH)D groups and pQCT parameters. Factors consistently associated with different bone parameters or those associated with 25(OH)D at p < 0.05 were considered for inclusion in multivariable models. Interactions between race and vitamin D cutoffs were assessed to evaluate if the association between 25(OH)D and pQCT parameters differed by race. A test of linear trend across categories of 25(OH)D status was also performed based on the ordinal value for each category. To further explore these relationships, we performed a spline analysis to test for possible thresholds and linearity for all bone parameters. Restricted cubic spline regression was used with knots at the fifth, 25th, 75th, and a reference group at the 95th percentile was set to create the spline plot. Threshold effects were evaluated by identifying potential inflection points on the spline and performing a test of equality to determine if the slopes above and below the cut point were equal. If more than one cutoff was identified (p < 0.05), we chose the 25(OH)D value with the lowest p value as the threshold. Spline plots were displayed if 25(OH)D thresholds were found. Secondary analyses using 25(OH)D tertiles based on the distribution of the entire population were also conducted. Results did not differ when comparing 25(OH)D tertiles and clinical cutoffs (findings not shown to avoid redundancy). All statistical analyses were performed using the statistical analysis system (SAS, version 9.1; SAS Institute, Cary, NC).
Results
Men of African descent had greater serum 25(OH)D than Caucasians (34.7 vs. 27.6 ng/ml, p < 0.001) ( Table 1) . Caucasians were older and had greater BMI, caffeine intake, and dietary calcium intake than men of African descent. Caucasian men were also significantly more likely to have a college education, take calcium supplements, report good/excellent health, history of a fracture, and hypertension. Men of African descent had a greater prevalence of diabetes than Caucasians (p < 0.001). 
Restricted cubic spline analysis
There was evidence of a threshold effect on tibial total BMC (p for test of non-equal slopes = 0.026) at 19 ng/ml of serum 25(OH)D among men of African descent (Fig. 1) . For tibial cortical thickness, a threshold (p for test of nonequal slopes = 0.011) was also identified for serum 25(OH) D at 18 ng/ml (Fig. 2) . Among Caucasians, we observed no significant thresholds for any of the bone parameters.
Discussion
There are limited data available on the relationship between 25(OH)D and bone quality measures in men of African ancestry. Among community-dwelling older men, we found that the association between serum 25(OH)D levels and pQCT measures differed by race. Among Caucasians residing in the US, there were significant associations of 25(OH)D with cortical vBMD, BMC, cortical thickness, SSIp, and SSIx; however, in men of African descent residing in the Caribbean, associations noted between 25 (OH)D and pQCT parameters were primarily null. The distribution of serum 25(OH)D varied substantially by race and few men of African descent were 25(OH)D deficient. Thus, it is imperative to interpret these findings with caution.
The statistically significant interactions that we observed suggest that race may modify the association between 25 (OH)D and these skeletal parameters. In Caucasian men, the associations were largely positive between 25(OH)D and total BMC, cross-sectional area, and SSI at the distal radius while in the African ancestry men these associations were either null or negative. We also found that Caucasian men with 25(OH)D sufficiency had lower trabecular vBMD than deficient men. On the other hand, men of African descent who were 25(OH)D sufficient had greater trabecular vBMD than those who were deficient. A previous study did not find a significant race by 25(OH)D interaction effect on measures of aBMD at the hip, lumbar spine, or radius among Caucasian, African American, and Hispanic men [6] ; however, the men in this study were significantly younger (mean age, 48 years) than those in our study, possibly contributing to the different findings.
The mean serum concentration of 25(OH)D was substantially higher in the African ancestry compared with Caucasian men in our study. Possible explanations for this observation include a higher exposure to sunlight, lower BMI, and lower smoking and alcohol consumption among the men of African descent. African Americans typically have lower levels of serum 25(OH)D than Caucasians across all age groups and both genders due at least in part to differences in skin pigmentation and dietary vitamin D intake [2, 23] ; however, mean 25(OH)D concentrations in the African continent are relatively high, but vary considerably according to geography, climate, and other factors [24] . There are limited data in other African ancestry populations, particularly in tropical climates where there is high sun exposure such as on the Caribbean island of Tobago where our subjects were recruited. Several studies have examined the cross-sectional association of 25(OH)D and bone measures in men [2, [7] [8] [9] [10] 25] . Similar to our findings, the MINOS study found that 25(OH)D levels measured with RIA were positively associated with cortical thickness (p < 0.05) and BMC (p < 0.01) at the femoral neck in older (ages 56-85) Caucasian men after adjusting for age, body weight, testosterone concentration, and season [9] . Similarly, the Rancho Bernardo study reported that 25(OH)D (measured with a competitive binding protein assay) was significantly and positively associated with aBMD at the hip, (p = 0.01) and spine, (p = 0.001) among 414 Caucasian men who had a mean age of 74 years. Conversely, another study that included 372 men aged 65-96, found that serum 25(OH)D (measured with RIA) was not associated with cortical vBMD in Caucasian men.
Fewer studies have examined the association of 25(OH) D with measures of skeletal health in ethnic minorities [6, 10] . The National Health and Nutritional Examination Survey (NHANES III) found a positive association between 25(OH)D measured by RIA and total hip aBMD in Caucasian, African-American, and Hispanic-American men aged 50 years and older; however, the mean difference in aBMD between the highest and lowest quintile was larger in Caucasians (0.040 g/cm 2 , p < 0.001) than men of African descent (0.024 g/cm 2 , p = 0.03) after adjustment for potential confounders [10] . On the other hand, Hannan et al. found no association between 25(OH)D and hip, spine, and radius aBMD among 331 black men in Massachusetts [6] . We also found no associations between 25(OH)D and volumetric BMD in men of African descent; however, at the distal radius, men of African descent had lower crosssectional area, SSIp, and SSIx with greater 25(OH)D concentrations (although the associations were relatively weak). There is no clear explanation for why men of African descent would have lower bone size and strength with higher 25(OH)D. Men of African descent have been shown to be resistant to the resorptive effects of parathyroid hormone (PTH) [26] . Also, intermittent and chronic PTH regimens have been shown to stimulate osteoblastic bone formation at the periosteal surface and postpone osteoblast apoptosis resulting in greater cross-sectional area and cortical thickness and thus bone strength with treatment [27, 28] .
The associations between 25(OH)D and bone measures were only observed at the distal (cortical) bone regions of the radius and tibia. Consistent with our findings, Lauretani et al. found that 25(OH)D was positively associated with tibial cortical vBMD, but not trabecular vBMD in women [25] . The mechanisms responsible for the differential associations of 25(OH)D with cortical versus trabecular bone are unclear. PTH excess has been shown to have primarily catabolic effects on cortical bone and maintain or even have anabolic effects on trabecular bone [29] . Several studies have shown that PTH administration and elevated serum PTH levels are associated with preserved trabecular bone structure [30] [31] [32] . In cortical bone, excess levels of PTH can result in increased endocortical resorption, cortical thinning, and cortical porosity [30, [32] [33] [34] .
Serum 25(OH)D thresholds were identified at approximately 18 ng/ml for total BMC and cortical thickness at the distal tibia in men of African ancestry. The associations of 25(OH)D with tibial total BMC and tibial cortical thickness appear to be positive and linear at values less than the threshold and null above these values. The biological mechanism is unclear for why these thresholds would be limited to the distal tibia, but not the distal radius in men of African descent. Our data, among men of African ancestry, showed a primarily negative linear association at the distal radius and no trends at the distal tibia. For thresholds to be identified on a plot, a strong departure from linearity needs to be observed at a specific point. Among Caucasians, the strong linear positive associations between 25(OH)D and bone negated any prospect of finding significant thresholds. The optimal serum 25(OH)D concentration needed to maintain adequate bone density and geometry has not been established [35] . Optimal concentrations have been defined as those for which PTH levels plateau in the normal range [36] ; however, this definition has led to the reporting of a wide range of 25(OH)D thresholds, from 8 to 46 ng/ml. A previous cross-sectional study based on aBMD levels found a threshold at 31 ng/ml with a target of 37 to 41 ng/ml for 25(OH)D for men and women aged ≥ 20 years [10] . Recent cohort studies in older men and women found that hip fracture risk was reduced among participants with 25(OH)D levels >20 ng/ml [35, 37] . In addition, men with 25(OH)D levels below 20 ng/ml experienced greater hip aBMD loss while rates were similar at higher levels [3] . All of this evidence suggests that a lower 25(OH)D threshold may exist for bone density and geometry than previously recognized.
A recent report in the MrOS cohort found that the strongest predictor of non-vertebral fracture was SSIx (HR = 2.2 per SD decrease) [38] . There was also a 70% increase in the risk of fracture per SD decrease in total BMC of the radius. The difference between 25(OH)D sufficiency and deficiency (Caucasians) for total BMC, and SSIx in our study was approximately 0.4 SDs. A decrease in BMD of 0.5 SD can greatly increase the risk of an osteoporotic fracture in older adults [39] .
Numerous potential confounders varied considerably by race. Substantial lifestyle and cultural differences were observed between the two population samples. Men of African descent had markedly lower calcium intake, alcohol intake, physical activity, education level, and caffeine intake compared to Caucasians. Therefore, we are unable to infer whether race modified the association between 25(OH)D and skeletal parameters based on strictly biological differences, lifestyle disparities, or a combination of both factors. In the Tobago cohort, dietary factors were not measured using a standardized questionnaire similar to the Block FFQ in the MrOS cohort, therefore these measurements may not be as accurate. Our study adjusted for many factors; however, residual confounding is an issue in observational studies and cannot be eliminated. Also, this study did not control for PTH (not measured in MrOS) which may mediate the association between 25(OH)D and bone strength. Finally, some of findings may have achieved statistical significance due to chance; however, our study also has several notable strengths including the use of an LC-MS/MS assay to measure serum 25(OH)D, adjustment for many potential confounders, a relatively large sample of men of African descent, and the use of pQCT to measure both cortical and trabecular bone, vBMD, bone geometry, and indices of bone strength. In contrast to DXA, pQCT can estimate vBMD and distinguish trabecular from cortical bone.
In summary, men of Caucasian and African descent differed in the association of serum 25(OH)D levels to several skeletal parameters. Levels of serum 25(OH)D were more likely to be associated with bone measures in Caucasians than men of African descent in our study. 
